Purchases and Sales Made in Q4 2024 in Theravance Biopharma, Inc. (TBPH)
This table provides information about the institutional ownership of Theravance Biopharma, Inc. (TBPH) during Q4 2024. The information is specifically focused on institutions that hold shares of Theravance Biopharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 17, 2025
Q4 2024
|
Sg Americas Securities, LLC
|
BUY
|
- |
3.35K+ 21.13% |
$26.6K - $33.8K
|
19.2K
$201K
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
1.7KNew |
$13.5K - $17.1K
|
1.7K
$17.8K
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.02K+ 10.82% |
$8.07K - $10.3K
|
10.4K
$109K
|
|
Jan 16, 2025
Q4 2024
|
Ballentine Partners, LLC
Waltham, MA |
BUY
|
- |
246+ 1.91% |
$1.95K - $2.48K
|
13.1K
$137K
|
|
Jan 08, 2025
Q4 2024
|
Fortitude Family Office, LLC
Scottsdale, AZ |
BUY
|
- |
177New |
$1.4K - $1.78K
|
177
$1.85K
|
|
Jan 02, 2025
Q4 2024
|
Gamma Investing LLC
Foster City, CA |
BUY
|
- |
75+ 37.88% |
$595 - $756
|
273
$2.86K
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-130- 7.35% |
$1.03K - $1.31K
|
1.64K
$17.2K
|